Effect of ethanol, haloperidol, and lorazepam on cardiac conduction and contraction

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 6, 1996, Pages 792-798

  Medlin Jr , Richard P ^a   Ransom, Mary M ^a   Watts, John A ^a   Kline, Jeffrey A ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Conduction; Contraction; Ethanol; Haloperidol; Lorazepam

Indexed keywords

ALCOHOL; HALOPERIDOL; LORAZEPAM;

ALCOHOL INTOXICATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CONCENTRATION RESPONSE; DRUG ALCOHOL INTERACTION; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; HEART CONDUCTION; HEART CONTRACTION; HEART MUSCLE REFRACTORY PERIOD; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION;

ALCOHOLIC INTOXICATION; ANIMALS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; ETHANOL; HALOPERIDOL; HEART CONDUCTION SYSTEM; HYPNOTICS AND SEDATIVES; LORAZEPAM; MALE; MYOCARDIAL CONTRACTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 10544236110     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199612000-00009     Document Type: Article

References (34)

1. Goldney RD, Spence ND, Bowes JA. The safe use of high dose neuroleptics in a psychiatric intensive care unit. Aust N Z J Psychiatry 1986;20:370-5.
2. Tesar ET, Murray GB, Cassem NH. Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol 1985;5(6):344-7.
3. Kaneko S, Edwards JG, Goldie A, Fukushima Y, Sato T. Effect of haloperidol decanoate on the cardiovascular system. Jpn J Psychiatry Neurol 1991;45(1):73-7.
4. Sanders KM, Stern TA. Management of delirium associated with use of the intraaortic balloon pump. Am J Crit Care 1993;2:371-7.
5. Aunsholt NA. Prolonged Q-T interval and hypokalemia caused by haloperidol. Acta Psychiatr Scand 1989;79:411-2.
6. Mehta D, Mehta S, Petit J, Shriner MD. Cardiac arrhythmia and haloperidol. Am J Psychiatry 1979;136:1468-9.
7. Cruz FG, Thiagarajan D, Harney JH. Neuroleptic malignant syndrome after haloperidol therapy. Southern Med J 1983;76(5):684-5.
8. Kriwisky M, Perry GY, Tarchitsky D, Gutman Y, Kishon Y. Haloperidol-induced torsade de pointes. Chest 1990;98:482-4.
9. Sanders KM, Murray GB, Cassem NH. High-dose intravenous haloperidol for agitated delirium in a cardiac patient on intra-aortic balloon pump. J Clin Psychopharmacol 1991;11:146-7.
10. Thomas HJ, Schwartz E, Petrilli R. Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Ann Emerg Med 1992;21:407-13.
11. Clinton JE, Sterner S, Steinmachers Z, Ruiz E. Haloperidol for sedation of disruptive emergency department patients. Ann Emerg Med 1987;16:319-22.
12. Lenehan GP, Gastfriend DR, Stetler C. The use of haloperidol in the management of agitated or violent, alcohol intoxicated patients in the emergency department. J Emerg Nurs 1985;11:72-9.
13. Ettinger PO, Wu CE De La Cruz C, Weisse AB, Ahmed SS, Regan TJ. Arrhythmias and the "holiday heart": alcohol assoicated cardiac rhythm disorders. Am Heart J 1978;95:555-62.
14. Dyer AR, Stamler J, Paul O, et al. Alcohol consumption, cardiovascular risk factors, and mortality in two Chicago epidemiological studies. Circulation 1977;56:1067-74.
15. Brackett DJ, Gauvin DV, Lerner MR, Holloway FA, Wilson MF. Dose- and time-dependent cardiovascular responses induced by ethanol. J Pharmacol Exp Ther 1995;268:78-84.
16. Ganz V. The acute effect of alcohol on the circulation and on the oxygen metabolism of the heart. Am Heart J 1963;66:494-7.
17. Metzger E, Freidman R. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically iII. J Clin Psychopharmacol 1993;13: 128-32.
18. Faigel DO, Metz DC, Kochman ML. Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance. Am J Gastroenterol 1995;90:822-4.
19. Stark G, Stark U, Tritthart HA. Assessment of the conduction of the cardiac impulse by a new epicardiac surface and stimulation technique (SST-ECG) in Langendorff perfused mammalian hearts. J Pharmacol Methods 1989;21:195-209.
20. Detweiler DK. Electrocardiographic monitoring in toxicological studies: principles and interpretations. Adv Exp Med Biol 1983; 161:579-607.
21. Josephson ME. Clinical cardiac electrophysiology. Williams and Wilkins, 1993;2:74-95.
22. Brannan MD, Riggs JJ, Hageman WE, Pruss TP. A comparison of the cardiovascular effects of haloperidol, thioridazine and chloropromazine HCl. Arch Int Pharmacodyn Ther 1980;244:48-57.
23. Galizzi J, Fosset M, Romey G, Laduron P, Lazdunski M. Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors. Proc Natl Acad Sci USA 1986;83:7513-7.
24. Carpentier RG, Gallardo-Carpentier A. Acute and chronic effects of ethanol on sinoatrial electrophysiology in the rat heart. J Cardiovasc Pharmacol 1987;10:616-21.
25. Danzinger RS, Sakai M, Capogrossi MC, Spurgeon HA, Hansford RG, Lakatta EG. Ethanol acutely and reversibly supresses excitation-contraction coupling in cardiac myocytes. Circ Res 1991;68:1660-8.
26. Kojima S, Wu ST, Wikman-Coffelt J, Parmley WW. Acute effects of ethanol on cardiac function and intracellular calcium in perfused rat heart. Cardiovasc Res 1995;27:811-6.
27. Ogata N, Narahashi T. Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes. Br J Pharmacol 1989; 97:905-13.
28. Williams ES, Mirro MJ, Bailey JC. Electrophysiological effects of ethanol, acetaldehyde, and acetate on cardiac tissues from dog and guinea pig. Circ Res 1980;47(3):473-8.
29. Carpentier RG, Gallardo-Carpentier A. Effect of ethanol on guinea pig ventricular action potentials. J Electrocardiol 1981;14:333-40.
30. Wilt JL, Minnema AM, Johnson RF, Rosenblum AM. Torsade de pointes associated with the use of intravenous haloperidol. Ann Intern Med 1993;119:391-4.
31. Zee-Cheng CS, Mueller CE, Seifert CF, Gibbs HR. Haloperidol and torsade de pointes. Ann Intern Med 1985;102:418.
32. Tan HL, Hou CJY, Lauer MR, Sung RJ. Electrophysiological mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 1995;122:701-14.
33. Holley FO, Magliozzi JR, Stanski DR, Lombrozo L, Hollister LE. Haloperidol kinetics after oral and intravenous doses. Clin Pharmacol Ther 1983;33:477-84.
34. Greenblatt DJ, Shader RI, Franke K, et al. Pharmacokinetics and bioavailability of intravenous, intramuscular and oral lorazepam in humans. J Pharm Sci 1979;68:57-63.